Gerald Wisler, President and CEO at Omthera Pharmaceuticals, Inc. (OMTH), sold 4 shares at $8.00 ($32) on 2013-04-16, disclosed to the SEC on 2013-04-17.
Open-market sale of $32 OMTH by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.